Sanjeev Astana
CEO at Patanjali Foods
Replay available
Patanjali Foods (NSE:PATANJALI) Q1 2027 earnings call, held 2026-08-17. Watch the replay and read the transcript on 6ix.

On 6ix: 6ix.com/event/patanjali-foods-limited-patanjali-q1-2027-earnings-call
Automated transcript · Written by software from the replay's audio. It can mishear names and figures; the replay is the record.
0:00 Ladies and gentlemen, good day, and welcome to the Patanjali Foods Limited Q1 FY 'twenty seven Earnings Conference Call. This conference call may contain forward looking statements about the company, which are based on the beliefs, opinions and expectations of the company as on the date of this call. These statements do not guarantee the future performance of the company and may involve risks and uncertainties that are difficult to predict. As a reminder, all participant lines will be in the listen only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Please note that this conference is being recorded.
0:45 I now hand the conference over to Mr. Sanjeev Astana, CEO, Patanjali Foods. Thank you, and over to you, sir. Thank you, and good morning to everyone joining us today. A warm welcome to all of you on Patanjali Foods Limited's call to discuss the financial performance for q one FY twenty seven. I'm accompanied by the company's CFO, Kumar Rajesh Ji, along with Mr. Preenduja from Investor Relations and our IR partners, Strategic Growth Advisors. The results collateral have been uploaded on the stock exchanges as well as on company's website for your reference. Let me now take you through a quick snapshot of our financial performance for the quarter.
1:35 During the course of the call, we will be referring to the stand alone financials. We continued to build on this momentum, delivering our fourth consecutive quarter of highest ever quarterly revenues, supported by healthy growth in profitability. Specifically, revenue from operations stood at INR 11,337 crores, growing 29% year on year. Operating EBITDA for the period was INR $5.43 crores, with a margin at 4.80%, while profit before taxes stood at INR $4.53 crores, translating into PBT margin of 4%. Turning to the segmental performance now. Our Edible Oil segment delivered quarterly revenue of 8,505 crores, marking the highest ever quarterly revenue with growth rate primarily by the mustard oil.
2:29 Quarterly EBITDA margin came in at 5.22%. On the oil palm plantation front, the company generated highest ever quarterly revenue of INR $7.40 crores in Q1 FY twenty twenty seven. Revenues grew by 25% year on year. This growth is closely aligned with the Government of India's National Mission on Edible Oils, Oil Park, which has strengthened farmer viability pricing and planting assistance to drive India towards self reliance in edible oils. As of 06/30/2026, the cultivated area stood at 115,861 hectares with nearly 37% of the area in the prime yielding phase of seven to twenty five years against total allocated area of INR 6.63 lakh hectares.
3:19 Turning now to our FMCG segment. The quarterly revenue stood at 2,938 crores with EBITDA of INR 190 crores and EBITDA margin of 6.45% in Q1 FY 'twenty seven. This segment contributed nearly 26% of revenues and nearly 30% of EBITDA, excluding unallocated income during the quarter. Within FMCG by category, the business generated revenue of $5.60 crores, registering year on year growth of 27%, reflecting continued consumer trust and preference, with EBITDA margin of 15.35% versus 9.35% in the same period last year.
4:05 Revenue from Consumer Staples segment stood at more than 1,000 crores in Q1 FY 'twenty seven. So on confluence of weather and geopolitical factors are expected to create some challenges here, but healthy government gain inventories and timely policy intervention should help mitigate the impact. The Textured Share Product division recorded revenue of 160 crores in Q1 FY 'twenty seven, growing 14% year on year and 50% quarter on quarter with EBITDA margin of over 18%. Our portfolio generated revenue of INR38 crores driven by extended summers aided by delayed onset of monsoon as well as new product launches including mango chutney, mango panna juice and orange juice.
4:53 Heat sales were softer during the quarter and generated revenue of INR $2.19 crores, reflecting the seasonal nature of demand and lower summer offtake in export oriented markets, particularly in The Middle East, where geopolitical tensions disrupted normal consumption and trade patterns. Our other food categories, including honey, dry fruits, spices and condiments, herbal products, etcetera, collectively generated revenues of INR $20.03 crores during the quarter. Revenue from Aesthetic was stood at INR 18 crores with Sports Nutrition gaining significant momentum. Our Home and Personal Care business delivered a strong performance with a total revenue of INR $6.29 crores in Q1 FY 'twenty seven. Within the category, the skincare emerged as a major revenue growth driver and dental care in stock on EBITDA and EBITDA margin side.
5:45 The dental care segment generated revenues of $3.45 crores followed by skin care at $1.65 crores. Home care revenue stood at 83 crores while hair care and other products generated rupees 56 crores. Let me now give you a brief overview of the operating environment. With the combination of Relayed Monsoon and Red Shaceship Oncrete, we saw commodity price inflation in Q1. This cuts both ways for us. On one hand, we carry long positions in Edible Oils, so the resulting commodity price inflation has actually been a net positive for the business. On the other, the same inflation raises input costs for several of our FMCG businesses, weighing on their profitability. Net net, the impact on Patanjali as a whole is smaller than it would be for a pure play FMCG company, where we are operating in a challenging environment through this quarter and into the next.
6:41 In Edible Oils, we have witnessed substantial drop in veg oil EBITDA last year. This, however, we have seen inflation returning in volatile veg oil markets, driven largely by petroleum prices and genuine supply shortages across the spectrum. This is working in our favor, offsetting much of the input cost pressure elsewhere in the portfolio and keeps us on course to deliver both the growth and the overall margin construct we have guided to for the company even after accounting for the raw material inflation flowing through the pump delayed monsoon. In this dynamic environment, we remain agile on pricing as input first of all. We took calibrated price increases in the AWS segment while using targeted discounts in our FMCG portfolio to remain competitive.
7:33 We also introduced a smaller pack sizes to address changing consumer needs and market requirements. This calibrated approach to pricing and fact architectures has helped us navigate the environment effectively. Such pricing measures are continuing in the current quarter as well as across the industry. Despite some delays in the monsoon, recent data on Swimov curries, including rice, pulses, coarse cereals, sugarcane, etcetera, has showcased resilience. Acreage gap has narrowed to 1.9% within last year. In fact, oilseeds saw a rise in the area, which is expected to get further boosted by steady growth across growing regions. On the input front, the thermal prices, which began firming in March 26, remained positive following the onset of the war, but turned marginally lower after de escalation in the latter part of the quarter.
8:25 Futures factored in the same prices turned lower. Still domestic prices were supported by rupee to premium of 2.5%. And again, by such period, palm oil prices reached two week high in mid August. The soy oil price reaches increased by 40% towards the end of March and stabilized towards the end of June. The stock price was directed by 66%, a much lower demand, leading to a sharper decline in physical prices, which further showing similar to palm line price trend. In the current environment, physical oriented hedging strategy rather than reliance on futures alone, along with timely import purchases, helped us in capturing divergence and improve the margins. Wheat prices have remained largely stable during the quarter, while milk prices trended upwards on the back of higher procurement costs.
9:16 Sugar prices remained firm amid lower domestic production and tighter inventory levels. Certain home and personal care products continue to face elevated input cost pressures. In addition to all, we saw an increase in packaging, freight and logistics costs during the quarter. Let me now move on to some of the other key business updates for the quarter. I want to take a moment to share some updates on our team. Our CFO, Kumar Rajesh, was honored with the best CFO of the year award of the Asia Business Leader of the Year Awards. On behalf of the entire team, I want to congratulate him on this well deserved honor. During the quarter, we won several new products, including Roast Kampi Soap, Dans Kampi Sensitive Toothpaste, super dish wash liquid, sweet lime pickle, hazmat and sourdough cookies in addition to our summer focused largest.
10:15 We've also rolled out range of new country variants that are performing extremely well. We are increasingly micro segmenting this portfolio by population, by Charles architecture and specifically to address the Gen Z requirements for the toothpaste. The staple category is expected to see the most rural stress related pressure this quarter, while home and personal care overall should continue to grow well. On the distribution front, we continue to strengthen our presence across e commerce and quick commerce channels. We remain confident in Patanjali's own right to win health, wellness, yoga, Ayurveda and what I'd call the Indianness of our proposition remain a core. Differentiated category for us in a market that is self expanding. We feel strongly and comfortably positioned to keep growing at the pace we have guided to, even as the overall FMCG landscape becomes more competitive and different players go about it in different ways.
11:13 I want to reaffirm a full year guidance range we have laid out for the business. Edible oil margin construct between 3% to 5% volume growth for the year. Food and FMCG, 8% to 10% growth with Beauty and Personal Care growing at around 15% FMCG vertical EBITDA growth at 12% to 15% for the year. On that note, I would now like to open the floor for questions and answers. With this, I conclude my opening remarks and hand it over for the q and a session. Thank you. We will now begin the question and answer session. Anyone who wishes to ask a question may press star and one on their touch tone telephone. If you wish to remove yourself from the question queue, you may press star and two. Participants are requested to use handsets while asking a question.
12:02 And gentlemen, we will wait for a moment while the question queue assembles. The first question comes from the line of Avnish Roy with Nuvama. Please go ahead. Yeah. Thank you. My first question is on the dish wash. In the dish wash category, we have seen one large MNC temporarily kind of exit the market. And we are also obviously, that announcement has come that could reach consumer once we exit the liquid dish wash. Currently, obviously, this segment is dominated by India's largest company, FMCG company. So wanted to understand what is your thought on getting success in this segment?
12:48 And do you see a big potential given the segment is currently seeing less competition because of that M and C marketing? Thank you. Yes. So, Abhish, but look, the Dishwash is actually a fairly strong both as a category and as a line that we have, and it has done exceedingly well. So we have no intention of either exiting or slowing down on that. We'll continue launching on the variance. That market is expanding. And to be specific name of the companies that you mentioned, that is a more a personal decision they have made on the corporate level, what might have been decided, but we are pretty much doing quite well in that segment. I don't have the number readily available specifically for the dish wash part of it, but very happy to share that with you post this call.
13:43 Understood. My second question is on biscuit. So last six months in Biscuit industry, we have seen two, three players operated the order pricing, 4.59. So if you could tell us now that mostly everyone has exited, how does this impact the overall growth for the market leader and for you also? So again, my... Actually, it's one of our stronger, you know, stories or good success stories of our brand has been that how we've kept not just the quality part exceedingly in control, have kept the unique positioning being the only ARTANJALI Biscuit player in the marketplace and have grown that consistently.
14:28 So that brand of Good Biscuit that we have in the category of INR 5 and INR 10, we do almost INR 1,300 crores of business annually. So it's a huge brand for us. And beyond the threshold, as you would see that even the EBITDA margins have continued to expand quarter on quarter and year on year. So this quarter, for example, we did nearly 15% plus in EBITDA on the Biscay. And I would say that very substantial part of that has been driven by at the back of the success of Bloom Biscuit on continued expansion. While we balance the portfolio of biscuits by launching as we mentioned that both the almond cookies and the seven plus cookies which were launched, there are three of products towards the premium end of the offering that we are planning.
15:18 But we are very committed. We see a very positive growth in that segment, and we continue to remain very active in that segment. Yes, we might go towards maybe premium group biscuits. We might look at more variants in line with the brand building that has happened over the years. But otherwise, we are very committed to INR 5 and ten sort of price points at which we are doing. And I think that's served exceedingly well the company's objective overall. Sure. Last quick question. When I see your initial comments on Staples and your recent media interviews, I find your comments a bit on the cautious side. And if I see the Q1 call of other Staples company, generally, they are reasonably positive.
16:07 Of course, price cycle further accelerate. And on the volume demand side also, generally, are quite okay. No one is sounding overly cautious. So I want to understand, one, why there seems to be some difference? And second, what kind of price hike, if you can tell us, you have taken in which categories? So there are two factors which are driving this caution, and I think you'll see that unfolding over this quarter and the subsequent quarters. One is that this as we know the impact is still very unclear in the way how markets are going to react both on the production side and the availability side. And very direct impact of that could be on the food inflation, which is there, number one. Number two is that the rural incomes and the rural market demand side, we'll have to watch with great deal of care as to how they play out.
17:11 If at all, we see some stress and resurfacing of some demand contraction there. I'm largely very positive in terms of the price outlook on the and bullish on the commodity pricing. And so that has both sides. One is that in terms of the top line growth, it can continue to succeed. So that's why I'm very much aligned on that. But in terms of the margin and the demand side of it and in terms of how that goes out, I think there we'll see some potential challenging environment I see definitely there. And this may also have an impact on the margin construct. But the most important part is that we still have to see that the reaction from the policy side, if indeed we see back to certain commodities, control order and essential commodities, etcetera, in location of that. So we'll have to wait for that. I think so that's why I've been a little cautious on that front.
18:11 But overall, staples will continue to grow. There's no question about it. So that we are positive ourselves. And we have, in any case, given a guidance of 8% to 10% growth on the stable side in the overall Food business also, and we pretty much stay true to that. Sure. Thanks. That's all from me. Thank you. The next question comes from the line of Abhishek Mathur with Systematics Group. Please go ahead. Yes. Hi, Sanjeev sir. Good morning and thank you for the opportunity. Sir, this the Foods segment seems to have recovered quite well this quarter after some time. Just wanted your thoughts on what is leading this recovery across both ethnic foods as well as the staples seems to be quite strong turnaround.
18:59 Yes, that's my first question. Yes. So we had a very good as was mentioning earlier that both in terms of the volumes and in terms of the revenue, so there has been an inflationary sort of buoyancy, which has driven that. So growth versus sequentially, if I look at the previous quarter itself, our overall, the revenues of staples have grown almost INR $2.60 crores, so which is 30% growth and we do have a fixed group size, there was some contraction that we witnessed. But net net, the overall expectation is that this will continue to grow partially by volume and balanced by the price inflation that we are expecting to see across the board.
19:50 The second part is that there was an extra focus you know, some of the unique product categories that we have, like, and rice, etcetera, where we saw the immediate in the... Both the demand side and the pricing side. So we benefited from that. And I think we'll continue to drive that to growth. We've come out with new variants also, both on the lentils on the pulsed side as well as on the side of basin, etcetera. So we are seeing some bit of the added sort of demand as it is getting driven. And company will continue to focus. So while it generates lesser margin, but it is one of the good indicators or as to the reach that it develops in Builder and completes our presence in the kitchen.
20:38 So that is something which is a stated target that the company has and which we continue to sort of work towards. Right. So just as a follow-up, what was the approximate breakup of the growth in Foods in terms of pricing that you took for the quarter and the volume growth? So overall, the volume growth has been around 7% to 8% is what we have seen across the segment. And so total okay, so I've just got the specific number. The volumes have grown by 5% and the pricing inflation that came in was almost about 12%. Understood, sir. And secondly, maybe in case I missed, what was the EBITDA number for our HPC for Staples and for Ethnic Foods, these three divisions separately, if you can give it out?
21:31 Yes. So for ethnic foods, our EBITDA was INR 9 crores. And for the HPC as an overall basis, Overall HPC EBITDA was 122 crores. Right, sir. And and for staples? For staples, as a category, we had negative 59 crores. Understood, sir. Thanks. That's it from me. All the best. Thanks. Thank you. The next question comes from the line of Sanjay with RSS Investments.
22:30 Please go ahead. Hello. Sanjay, please go ahead with your question. Hello. Good morning, management team. So my first question is regarding the current situation in the case with the Asha advisory. What is the current situation? So that we can... Because it is not a subject, we can take it up, and we can discuss it post the call. So how how how should I connect to you What's the phone? Hello? I said you can take our number from the SEA advisers, and you can reach out to us, and we can discuss that separately.
23:23 Sir, my second question is regarding the nutraceutical deal going in the international market. Are you aware of that? Megatronic buying being capital buying. Sir, some Hello? I would not be able to copy this. I don't have the specific details of these deals. I would not be able to comment on that. Sir, for example, Bain Capital buying Beta Biotics at a very huge price. I just want to know your comment on that. So I can give you a general comment, not on the specifics of Bain Capital's acquisition. The Intraceuticals is one of the fastest growing segments in the health and wellness space across the board and this is across the world itself.
24:18 So yes, I think in India also you're seeing the proliferation of brands and companies which have gone into the segment. We ourselves did serious amount of work on nutraceuticals. Then we took a step back, reconstructed our entire portfolio, started building that up, and we've turned positive now from earlier marginal negatives that we are witnessing. We have now turned positive, and we continue to continue to grow that. And I'm hoping that, you know, it will become one of our stronger performing businesses in the future. Okay, sir. Thank you. That's all. That's all. You. The next question comes from the line of Rohit Kumar with ADM Advisors. Please go ahead.
25:07 Rohit, please available? Yes, Ruet. Please go ahead. Yeah. Ruet, please go ahead with your question. Yeah. Hello. So my first question was on the... Since we have seen that historically, we have observed that TSP doing well in terms of when we when we observe higher food inflation. So are we observing similar trends currently as well? Sorry. Your question was related to the TSP. Right? Yes. Okay. And what was the question? Can you repeat that again, please? It was slightly muffled.
25:53 Yeah. So in... Historically, we have seen that TSP are doing well when the... When we observe higher inflation, food inflation. So are we observing similar trends currently as well? No. TSP for others look... You're right. In fact, TSP at a higher commodity inflation tends to do not so good. But neutralize a strong brand. We nearly have 40% market share. And so this quarter, for example, we did INR 150 crores of business, and we had 18 plus of EBITDA margin on that. So because the commodity soybean prices tend to go up sharply and our ability to pass through that price increase regularly is limited.
26:42 So typically, it tends to do less better. And overall, this is becoming a hypercompetitive space as well. But we are quite confident that we'll continue the guidance that we've always given us that our margins will be 16% to 18% on the TSP. I think we'll be able to maintain that. We're doing a little bit better than 18%, but I'm confident that we'll maintain that for the year as well. Okay. And sir, looking at the current environment, how are we looking at the revenue contribution from the FMCG segment in coming quarters? So in coming for this year, last year, we've been close to 10,000 crores of revenue.
27:29 And this year, overall, my expectation is that we will process we have given a guidance of more than 10% to 12% growth we overall witnessed. So for example, last year, our total sales from FMCG overall was including the HPC was INR 11,000 plus. And this year, my estimation is that we should certainly cross increase it by 10% plus and we should be somewhere closer to INR 12,500 crores in our revenues. Okay. And sir, one last question. If we look beyond FY 'twenty seven, what are the biggest structural reverts that can take Patanjali Foods from its current earning potential to a significantly higher ROCE and EBITDA margin business?
28:21 Will it be FMCG mix or it will be premiumization or it will be higher distribution productivity or backward integration or maybe something else? Can you put some light on it? Yes. So look, there are three factors which are driving the growth of Patanjali's businesses and profitability. One is the strong momentum that we have on the pipeline plantation. And we've consistently shown a growth. This year, our anticipation is that we should have a growth momentum of more than 15% again on our business. And that on a structural basis is going to become a larger profit generator and a consistent margin generator for the company. That's why. Second is, there is an effort across the board that the high profit making kind of businesses like HPC and similarly Nutella and biscuits.
29:28 We will expand our margin construct in that. So that will be the big second big driver of the growth. And the third is that in terms of superior risk management that we have in terms of the brand building that we do on the edible oil side, How do we increase our margin construct typically what we say between 24% towards consistently 5% plus will be a big driver of growth. So if you notice that our performance across all the business categories have shown very good performance other than one or two blips that we have on the food side. This is also by way of abundant caution in terms of some inventory markdown in case of certain quality issues that we saw in pulses in the stocks that we had.
30:20 And the higher input inflation in terms of packaging, in terms of commodity and otherwise, which has had some impact on our overall Foods business. Our margin construct across the board is very strong. We continue to perform exceedingly well in biscuits, neutralize very good, which continues to sort of outdo itself in terms of projections. Nutraceuticals has turned the corner. Oil plantation is doing exceedingly well. Our fresh business is doing very well. Our edible oils category is doing very well. The only blip that we had this quarter was on the food side. And within food specifically on the staples and partially on the ethnic foods that we are reasonably confident that we'll be able to fight over it. There is some challenge that the industry is also facing that we are also facing.
31:13 So net net in terms of the overall growth momentum, these steps I believe is going to drive our growth in the future. And in terms of the next trajectory level of moving closer to INR 2,500 crores of EBITDA, hopefully, I think over the next eighteen months on an annualized basis, I'm reasonably confident that we should be able to head in that direction. Thank you, sir. That's it from my side. Participants, please press star and one to ask a question. The next question comes from the line of with Billion Securities. Please go ahead. Yeah. Hi. Thank you so much for the opportunity.
32:01 I just have two questions. First, how are our newly launched products performing in the industry? And how is pipeline of the upcoming products looking? So sorry. What was the first part of the question? How... The the relaunch of what? No. No, sir. I just wanted to know how are the newly launched products performing in the industry, and what is the upcoming pipeline of products that we're looking at? Okay. Okay. So the newly launched products in general have tended to do well. And as you know that, you know, the success rate is always dependent on factors of the market acceptability, etcetera. So we do have a part that between 30% to 35 of the products that we launch typically do not tend to do as well. And then either we tweak them or work through that. But our success rate, I would say, 60% of our launches typically tend to do well in the marketplace, and they take take time in terms of further attention and drive that we have to get. And balance set of products, if we...
33:13 If they are not up to the level, then either we tweak them, either we reorient them, we work towards that. So it's I would say two third, one third is a success rate. Our pipeline for new product development, I would say, is among the better performing parts of the Patanjali, where our ability to innovate and come out with products with in a good succession. So our new product development sort of teams are constant work that we do in the marketplace, I think one of the stronger points that we have. So you will see in the coming quarters a few of new products that are getting launched in the HPC category, a few of products that we are working on in terms of the multiple variants that we have on the as I mentioned in the initial remarks as well, on the dental care, on the skin care, there are large number of products. On the biscuits, we launched multiple different new products. So I think there's a very strong sort of architecture of layered new launches that we do. And I'm quite confident that, you know, we will see a reasonable success rate in these newly launched products.
34:27 Okay. Thank you so much, sir. That is quite helpful. My next question is, you know, competitors are going big on e commerce and quick commerce platforms as a mode of distribution. How are we looking at these channels, and what kind of revenue contribution can we expect from these channels? So we are very strong. As I had mentioned in the past that we are growing at 25% year on year on the both e commerce and e commerce. Currently, if I were to put those numbers together, we right now do close to about 15% between modern trade and e commerce, e commerce. We want to take that number up to 20% and I'm confident that over next eighteen months, we will see our numbers reaching 20% of the overall revenue through these channels.
35:17 So we are available across the board on all these platforms and we continue to increase our presence on that basis. So we have moved up in last fifteen months from 12% to 15% taking it from 15% to 20% is one of the stated objectives the company has on these emerging distribution channels, and we continue to drive that growth. Okay. That's quite helpful, sir. That's it from my side. Thank you. The next question comes from the line of Keshav Harlalga with BHH Securities. Please go ahead. Hi. Hi. Thank you so much. Is this Sanjay Vasana, sir, I'm speaking with? Yes. Yes. Hi, sir. So I was sitting behind you when Ramdev Baba came to BSC in July to give a presentation.
36:07 Oh, okay. Okay. Okay. Our stock price crashed 14%. So I have a question that we have acquired. We have paid 1,100 crores, and we have acquired Patanjali Airways home and personal care business. As far as we have paid paid purchase concentration of 1,100 crores. So there is some misgiving in the market that we have overpaid for this acquisition. So can you give us some color? Can you give some release on BSE and NSE? What is the valuation methodology we have followed and how shareholders are benefiting from this acquisition? And how will the numbers look for... Because we have acquired it in July, I think we'll see the numbers from this quarter onwards. So how will the numbers be better and different this quarter onwards versus the corresponding quarter previous year? What is the fee multiple we've acquired the business at? What kind of earnings can we... What kind of earnings addition can we see for this new business we've acquired?
37:02 So I'll... First of all, let me tell you, there is no earning multiple or nothing. It has almost come free to Patanjali Foods Limited entity. We paid on a slump sale basis in November 24 on the business, which has generated almost 600 crores of EBITDA margin last year. So we... If my numbers are right, Rajiv, what we paid 1,100 crores or $9.50 crores? 1,100. So it is a business of... You know, it was 2,900 crores. It was generating a margin of 600 crores, and we have paid 1,100 crores, which is less than eighteen, nineteen months of quality. And which is already in last eighteen months, it has already repaid that much and built up our business substantially.
37:51 So that answers your questions later. There was no valuation methodology. Nothing. It was just the state of on a from sale basis that we sold... We acquired the business. So, basically, Patanjali Foods is quoting at a p multiple of 20. So we basically acquired it for all use free. So I'm just saying that if you can give some clarification, some valuation, some some slum sales that the shareholders have got a very good deal, This price fall from $41.05 to $3.45, disconcerting. So if we can give some clarification to NSE and BSE, some valuation, some note we can give it to definitely help all the shareholders, sir. So that was It's just a suggestion from my side. Sure. So, Rajesh, I'll just answer, then you then you give your Yeah. Yeah. Yeah. Yeah. That's very significant. We have done three acquisitions, you know, in the...
38:41 But in the business, and Patanjali Foods Limited entity. The first one that we acquired was biscuit business, then we acquired the foods business, and then we acquired the HPC business. All the three businesses we acquired on a slum sale basis, which is basically just the assets that we paid for and the inventory that they carried at that point of time. There's no evaluation methodology. There was nothing. So this was almost gifted by the parent to the listed entity and at a some sale basis, which is a standard methodology of how the transaction can be done under the Indian law. And they cannot be a better form of these acquisitions, which has tended to help us with the level of and they have paid for example has paid multiple times of acquisition cost.
39:33 The amount of similarly the food business has already paid off completely what we acquired it for. And likewise for HPT, that's already paid up for that. So I don't think it requires any clarification on this bit because there's a complete, you know, miss... Misconception or complete wrong piece of information that they carry, which just makes no sense at all. And I Thank you. Thank you, sir. Yeah. I would like I would like to further add, this information was already given into the stock exchange at the time of acquisition of this business to Patanjali Foods Limited. Basically, detailed detailed explanation was given to the stock exchange in the shareholders meeting also.
40:18 So it... The... All these transaction was approved by the shareholder... Shareholders in the shareholders meeting. So I don't think any further clarification is required in this case. Got it. Got it. So just one last question from my end. So we showed a 84% growth in profit in q one of this year versus q one of last year. So can we see a similar trajectory going forward for Q2, Q3, Q4? Can you give us some light on what we could expect for these coming three quarters? No. So as I mentioned that I think, you know, the performance is subject to obviously the market condition. But broadly, the guidance that we have given, I'd like us to stay within that, that we will grow at the rate of 10% plus year on year on the margin construct.
41:08 And that is how it is going. Our top line, I've already mentioned that foods overall between 8% to 10%, HPC at 15% and our edible oil between 24% And margin constructs in the debt on EBITDA margins overall basis, we should be between 10% to 12% growth in the margin construct as we go forward. Okay. Thank you. Thank you so much, sir. Thank you so much, sir. Ladies and gentlemen, as there are no further questions, I would now like to hand the conference over to Mr. Sanjeev Astana for the closing remarks.
42:00 So with this, I conclude the call. I sincerely thank you for your continued support and trust in Patanjali Foods. If you have any further queries, please reach out to us at Investor Relations at Ygrene. Thank you very much. Thank you, sir. Ladies and gentlemen, on behalf of Patanjali Foods Limited, that concludes this conference call. Thank you for joining us, and you may now disconnect your lines.
Follow Patanjali Foods Limited into a list and get an email when it puts out news.
CEO at Patanjali Foods
CFO at Patanjali Foods Limited
at Nuvama
at Systematics Group
at ADM Advisors
at BHH Securities